Plasma-Lyte 56 in 5 % Dextrose Injectable Solution
RxNorm 1189668
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1189668 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Plasma-Lyte 56 in 5 % Dextrose Injectable Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SY
Synonym (SY):
Glucose 50 mg/ML / magnesium acetate 0.0015 MEQ/ML / K+ Acetate 0.013 MEQ/ML / NaCl 0.04 MEQ/ML Injectable Solution [Plasma-Lyte 56 in 5 % Dextrose]
(Atom ID: 3863792)
SY
Synonym (SY):
Glucose 50 mg/ML / magnesium acetate 0.0015 MEQ/ML / Pot Acetate 0.013 MEQ/ML / NaCl 0.04 MEQ/ML Injectable Solution [Plasma-Lyte 56 in 5 % Dextrose]
(Atom ID: 3867125)
SBD
Semantic Branded Drug (SBD):
Glucose 50 mg/ML / magnesium acetate 0.0015 MEQ/ML / potassium acetate 0.013 MEQ/ML / sodium chloride 0.04 MEQ/ML Injectable Solution [Plasma-Lyte 56 in 5 % Dextrose]
(Atom ID: 12360232)
SY
Synonym (SY):
Plasma-Lyte 56 in 5 % Dextrose (glucose 50 mg/ML / magnesium acetate 0.0015 MEQ/ML / potassium acetate 0.013 MEQ/ML / sodium chloride 0.04 MEQ/ML) Injectable Solution
(Atom ID: 3863520)
PSN
Prescribable Name (PSN):
Plasma-Lyte 56 in 5 % Dextrose Injectable Solution
(Atom ID: 8725439)
SY